GGrantIndex
← Leaderboards

Xia Ning

Ohio State University

$3,689,500
Attributed
$9,274,551
Total exposure
6
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.8M · FY201825
$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,274,551 · 6

By mechanism

R01$8,874,359 · 5
R21$400,192 · 1

Top collaborators

Most similar at Ohio State University

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Alzheimer&Apos

Research focus

Alzheimer&AposAlgorithmsInnovationElectronic Health RecordDatabasesMachine LearningComplexCommunitiesPublic HealthClinical DataCognitiveProteinsBiological MarkersCellsFeedbackPhenotypeDesignCohortBaseImageDrug DiscoveryAmericanDrug DevelopmentCost

Grant awards (20)

Integrating eSAGE with EHR data using machine learning for the early detection and monitoring of cognitive impairment in individuals including those underserved$738,977
R01 · FY2025 · AG · contact PI
Translational big data analytic approaches to advance drug repurposing for Alzheimer's disease$714,545
R01 · FY2025 · AG
Generative AI for retrosynthesis libraries$330,004
R01 · FY2025 · LM · contact PI
Integrating eSAGE with EHR data using machine learning for the early detection and monitoring of cognitive impairment in individuals including those underserved$762,126
R01 · FY2024 · AG · contact PI
Translational big data analytic approaches to advance drug repurposing for Alzheimer's disease$745,370
R01 · FY2024 · AG
Generative AI for retrosynthesis libraries$330,713
R01 · FY2024 · LM · contact PI
Translational big data analytic approaches to advance drug repurposing for Alzheimer's disease$761,646
R01 · FY2023 · AG
COMPUTATIONAL TOOLS FOR PROTEOFORM IDENTIFICATION BY TOP-DOWNDATA INDEPENDENT ACQUISITION MASS SPECTROMETRY$294,904
R01 · FY2023 · GM
Translational big data analytic approaches to advance drug repurposing for Alzheimer's disease$777,939
R01 · FY2022 · AG
COMPUTATIONAL TOOLS FOR PROTEOFORM IDENTIFICATION BY TOP-DOWNDATA INDEPENDENT ACQUISITION MASS SPECTROMETRY$282,462
R01 · FY2022 · GM
COVID-19 disease course analysis using multi-site large-scale EHR data$170,884
R21 · FY2022 · LM · contact PI
Translational big data analytic approaches to advance drug repurposing for Alzheimer's disease$809,200
R01 · FY2021 · AG
COMPUTATIONAL TOOLS FOR PROTEOFORM IDENTIFICATION BY TOP-DOWNDATA INDEPENDENT ACQUISITION MASS SPECTROMETRY$287,090
R01 · FY2021 · GM
COVID-19 disease course analysis using multi-site large-scale EHR data$229,308
R21 · FY2021 · LM · contact PI
Enhancing information retrieval in electronic health records through collaborative filtering$541,639
R01 · FY2020 · LM
COMPUTATIONAL TOOLS FOR PROTEOFORM IDENTIFICATION BY TOP-DOWNDATA INDEPENDENT ACQUISITION MASS SPECTROMETRY$292,538
R01 · FY2020 · GM
Characterizing COVID-19 Patients through a Community Health Information Exchange and EHR databases$74,999
R01 · FY2020 · LM
COMPUTATIONAL TOOLS FOR PROTEOFORM IDENTIFICATION BY TOP-DOWN DATA INDEPENDENT ACQUISITION MASS SPECTROMETRY$60,245
R01 · FY2020 · GM
Enhancing information retrieval in electronic health records through collaborative filtering$533,290
R01 · FY2019 · LM
Enhancing information retrieval in electronic health records through collaborative filtering$536,672
R01 · FY2018 · LM